Skip to main content
Livermore
Livermore
US stocksTW
ZHEN

FMR LLC

SEC CIK
0000315066
Latest filing
Aug 13, 2026

The latest 13F from FMR LLC covers Q2 2026 (filed Aug 13, 2026): 5,562 long positions worth $2.30T. The top 10 holdings make up 34.0% of the portfolio, and the largest is NVIDIA Corp (NVDA) at 8.9%. Livermore has 37 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Full comparison

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

New
383
Est. +$58.4B
Added
2922
Est. +$172.6B
Reduced
1858
Est. −$172.3B
Sold out
227
Est. −$2.32B

Top 5 holdings

Share of this quarter's portfolio value

  1. NVDANVIDIA Corp
    8.9%$205.3BHistory
  2. AAPLApple Inc.
    4.1%$94.1BHistory
  3. GOOGLAlphabet Inc.
    3.9%$89.6BHistory
  4. AMZNAmazon Com Inc
    3.8%$87.2BHistory
  5. MSFTMicrosoft Corp
    3.0%$69.4BHistory

Share of portfolio

Top 5 holdings and the other 5,557 positions, by share of portfolio value

  1. NVDA8.9%
  2. AAPL4.1%
  3. GOOGL3.9%
  4. AMZN3.8%
  5. MSFT3.0%
  6. Other 5,557 positions76.3%

Biggest buys

New and added positions, by estimated amount bought

  1. SPCXSpace Exploration Technologies Corp
    +$51.7BNewHistory
  2. AVGOBroadcom Inc.
    +$7.65BAddedHistory
  3. UNHUnitedHealth Group Inc
    +$6.64BAddedHistory
  4. NVDANVIDIA Corp
    +$6.44BAddedHistory
  5. AMDAdvanced Micro Devices Inc
    +$5.97BAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. SPCXSpace Exploration Technologies Corp
    +2.24 pp0.0% → 2.2%History
  2. AMDAdvanced Micro Devices Inc
    +0.48 pp0.2% → 0.6%History
  3. INTCIntel Corp
    +0.44 pp0.1% → 0.6%History
  4. AVGOBroadcom Inc.
    +0.34 pp2.0% → 2.4%History
  5. UNHUnitedHealth Group Inc
    +0.33 pp0.2% → 0.5%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. MRVLMarvell Technology, Inc.
    −$22.1BReducedHistory
  2. SNDKSandisk Corp
    −$12.6BReducedHistory
  3. METAMeta Platforms, Inc.
    −$11.7BReducedHistory
  4. MUMicron Technology Inc
    −$6.16BReducedHistory
  5. NFLXNetflix Inc
    −$4.91BReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. METAMeta Platforms, Inc.
    −1.17 pp3.5% → 2.3%History
  2. MSFTMicrosoft Corp
    −0.70 pp3.7% → 3.0%History
  3. NFLXNetflix Inc
    −0.62 pp1.0% → 0.4%History
  4. XOMExxonMobil Holdings Corp
    −0.43 pp1.3% → 0.8%History
  5. SHELShell plc
    −0.18 pp0.5% → 0.3%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$2.30T
+$405.9B (+21.4%) vs. prior quarter
Positions
5,562
+156 vs. prior quarter
Top 10 concentration
34.0%
Top 10 as share of value
Turnover
8.3%
Q2 2026, one quarter
Average holding period
20.2 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $2.30T (Q2 2026)

Q1 2021: $1.17TQ2 2021: $1.28TQ3 2021: $1.26TQ4 2021: $1.35TQ1 2022: $1.25TQ2 2022: $1.00TQ3 2022: $958.9BQ4 2022: $1.01TQ1 2023: $1.09TQ2 2023: $1.19TQ3 2023: $1.16TQ4 2023: $1.30TQ1 2024: $1.49TQ2 2024: $1.56TQ3 2024: $1.64TQ4 2024: $1.68TQ1 2025: $1.57TQ2 2025: $1.77TQ3 2025: $1.92TQ4 2025: $1.96TQ1 2026: $1.90TQ2 2026: $2.30T
Q1 2021Q2 2026
13F filings of FMR LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 13, 20265,562$2.30TNVDAAAPLGOOGLvs. Q1 2026SEC
Q1 2026May 15, 20265,406$1.90TNVDAAAPLAMZNvs. Q4 2025SEC
Q4 2025Feb 17, 20265,408$1.96TNVDAMSFTAAPLvs. Q3 2025SEC
Q3 2025Nov 13, 20255,360$1.92TNVDAMSFTMETAvs. Q2 2025SEC
Q2 2025Aug 14, 20255,315$1.77TNVDAMSFTMETAvs. Q1 2025SEC
Q1 2025Nov 5, 2026Amended5,278$1.57TNVDAMETAMSFTvs. Q4 2024SEC
Q4 2024Nov 5, 2026Amended5,518$1.68TNVDAAAPLMSFTvs. Q3 2024SEC
Q3 2024Nov 5, 2026Amended5,472$1.64TNVDAMSFTAAPLvs. Q2 2024SEC
Q2 2024Nov 5, 2026Amended5,349$1.56TNVDAMSFTAAPLvs. Q1 2024SEC
Q1 2024Nov 5, 2026Amended5,337$1.49TNVDAMSFTMETAvs. Q4 2023SEC
Q4 2023Nov 5, 2026Amended5,419$1.30TMSFTNVDAAAPLvs. Q3 2023SEC
Q3 2023Nov 5, 2026Amended5,271$1.16TMSFTNVDAAAPLvs. Q2 2023SEC
Q2 2023Nov 5, 2026Amended5,362$1.19TMSFTAAPLNVDAvs. Q1 2023SEC
Q1 2023Nov 5, 2026Amended5,253$1.09TMSFTAAPLNVDAvs. Q4 2022SEC
Q4 2022Nov 5, 2026Amended5,336$1.01TMSFTAAPLUNHvs. Q3 2022SEC
Q3 2022Nov 5, 2026Amended5,304$958.9BAAPLMSFTAMZNvs. Q2 2022SEC
Q2 2022Nov 5, 2026Amended5,351$1.00TMSFTAAPLAMZNvs. Q1 2022SEC
Q1 2022Nov 5, 2026Amended5,434$1.25TMSFTAAPLAMZNvs. Q4 2021SEC
Q4 2021Feb 14, 20224,847$1.35TMSFTAAPLAMZNvs. Q3 2021SEC
Q3 2021Feb 14, 2022Amended4,794$1.26TMSFTAMZNAAPLvs. Q2 2021SEC
Q2 2021Aug 13, 20214,965$1.28TMSFTAMZNAAPLvs. Q1 2021SEC
Q1 2021May 14, 20214,377$1.17TMSFTAMZNAAPL–SEC

13D and 13G filings

Companies where FMR LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

481 companies, largest stake first.

Companies where FMR LLC owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
Fidelity Private Credit Co LLCCommon Units13G100.00%78.7M sharesNewAug 7, 20261 filingAug 7, 2026SEC
Fidelity Multi-Strategy Credit FundCommon Shares13D/A52.20%3.08M shares−1.20 ppfrom 53.40%May 26, 202324 filingsAug 19, 2026SEC
CBRSCerebras Systems Inc.13G/A17.80%30.3M shares−7.90 ppfrom 25.70%Jun 5, 20263 filingsNov 5, 2026SEC
SIShoulder Innovations, Inc.13G/A17.70%3.67M shares−1.30 ppfrom 19.00%Sep 8, 20252 filingsAug 6, 2026SEC
PIMCO ETF TrustCOMMON STOCK13G/A17.50%2.50M shares+4.30 ppfrom 13.20%Feb 9, 20227 filingsAug 6, 2026SEC
TXG10x Genomics, Inc.13G/A15.60%18.5M shares+4.80 ppfrom 10.80%Feb 8, 202113 filingsMar 6, 2026SEC
LXRXLexicon Pharmaceuticals, Inc.13G/A15.00%66.7M shares+3.30 ppfrom 11.70%Jan 11, 20218 filingsNov 5, 2026SEC
LFSTLifeStance Health Group, Inc.13G/A15.00%58.5M shares+3.00 ppfrom 12.00%Feb 9, 202210 filingsMay 6, 2026SEC
NUVBNuvation Bio Inc.13G/A15.00%50.6M shares+1.50 ppfrom 13.50%May 10, 20218 filingsMay 12, 2025SEC
BFLYButterfly Network, Inc.13G/A15.00%36.7M shares+3.20 ppfrom 11.80%Feb 9, 20224 filingsNov 5, 2026SEC
BETABETA Technologies, Inc.13G15.00%33.0M sharesNewDec 5, 20251 filingDec 5, 2025SEC
GPCRStructure Therapeutics Inc.13G/A15.00%32.1M shares+1.80 ppfrom 13.20%Feb 10, 20238 filingsNov 5, 2026SEC
OCULOcular Therapeutix, Inc13G/A15.00%31.8M shares+2.70 ppfrom 12.30%Jul 8, 20252 filingsNov 5, 2025SEC
WSCWillScot Holdings Corp13G/A15.00%27.1M shares+1.70 ppfrom 13.30%Feb 9, 20227 filingsMay 6, 2026SEC
TNGXTango Therapeutics, Inc.13G/A15.00%25.3M shares+8.10 ppfrom 6.90%Feb 9, 20227 filingsNov 6, 2026SEC
BRKRBruker Corp13G/A15.00%23.3M shares+2.60 ppfrom 12.40%Feb 8, 202110 filingsAug 6, 2026SEC
JBIJanus International Group, Inc.13G/A15.00%20.8M shares+2.10 ppfrom 12.90%Nov 12, 20244 filingsMay 6, 2026SEC
KBRKBR, Inc.13G/A15.00%19.5M shares+4.60 ppfrom 10.40%Jan 10, 20225 filingsAug 6, 2025SEC
COGTCogent Biosciences, Inc.13G/A15.00%16.6M shares–Feb 9, 20244 filingsFeb 12, 2025SEC
AMLXAmylyx Pharmaceuticals, Inc.13G/A15.00%16.5M shares+4.30 ppfrom 10.70%Oct 7, 20252 filingsFeb 5, 2026SEC
WRBYWarby Parker Inc.13G/A15.00%15.9M shares+6.20 ppfrom 8.80%Apr 11, 20229 filingsDec 5, 2025SEC
SRRKScholar Rock Holding Corp13G/A15.00%14.1M shares–Feb 8, 20216 filingsFeb 12, 2025SEC
IMNMImmunome Inc.13G/A15.00%13.1M shares+7.90 ppfrom 7.10%Feb 9, 20245 filingsOct 7, 2025SEC
AVIRAtea Pharmaceuticals, Inc.13G/A15.00%12.0M shares+3.40 ppfrom 11.60%Feb 8, 202110 filingsMay 6, 2026SEC
CBUSCibus, Inc.13G/A15.00%11.4M shares+1.10 ppfrom 13.90%Feb 8, 20217 filingsMay 6, 2026SEC

Showing the 25 largest of 481 stakes.

Latest filings

6,158 filings on file made by FMR LLC or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by FMR LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
CTYCity Therapeutics, Inc.Nov 6, 20269:46 AM ET13G14.00%7.03M sharesNewOct 30, 2026SEC
MAMAMama's Creations, Inc.Nov 6, 20269:45 AM ET13G/A13.50%6.35M shares+4.50 ppfrom 9.00%Oct 30, 2026SEC
SFMSprouts Farmers Market, Inc.Nov 6, 20269:45 AM ET13G/A9.10%8.36M shares−5.90 ppfrom 15.00%Oct 30, 2026SEC
UPBUpstream Bio, Inc.Nov 6, 20269:45 AM ET13G/A6.90%3.79M shares−7.90 ppfrom 14.80%Oct 30, 2026SEC
UWMCUWM Holdings CorpNov 6, 20269:45 AM ET13G/A11.20%40.4M shares+2.20 ppfrom 9.00%Oct 30, 2026SEC
LOVELovesac CoNov 6, 20269:45 AM ET13G/A10.40%1.49M shares+3.20 ppfrom 7.20%Oct 30, 2026SEC
ACIWAci Worldwide, Inc.Nov 6, 20269:45 AM ET13G/A10.10%10.2M shares+1.20 ppfrom 8.90%Oct 30, 2026SEC
SPDR Series TrustCOMMON STOCKNov 6, 20269:45 AM ET13G/A8.30%13.2M shares−8.20 ppfrom 16.50%Oct 30, 2026SEC
CTVACorteva, Inc.Nov 6, 20269:45 AM ET13G/A10.30%69.0M shares+1.90 ppfrom 8.40%Oct 30, 2026SEC
PENGPenguin Solutions, Inc.Nov 6, 20269:45 AM ET13G/A7.40%4.48M shares−7.60 ppfrom 15.00%Oct 30, 2026SEC
TNGXTango Therapeutics, Inc.Nov 6, 20269:45 AM ET13G/A15.00%25.3M shares+8.10 ppfrom 6.90%Oct 30, 2026SEC
OXMOxford Industries IncNov 6, 20269:45 AM ET13G/A0.00%1.84K shares−7.20 ppfrom 7.20%Below 5%Oct 30, 2026SEC
ASPEAspen Neuroscience, Inc.Nov 6, 20269:45 AM ET13G11.20%3.25M sharesNewOct 30, 2026SEC
HLMNHillman Solutions Corp.Nov 6, 20269:45 AM ET13G/A10.10%19.6M shares+1.10 ppfrom 9.00%Oct 30, 2026SEC
AGF Investments TrustCOMMON STOCKNov 6, 20269:45 AM ET13G/A0.00%394 shares−7.80 ppfrom 7.80%Below 5%Oct 30, 2026SEC
BYRNByrna Technologies Inc.Nov 6, 20269:45 AM ET13G15.00%3.51M shares+12.50 ppfrom 2.50%Oct 30, 2026SEC
Franklin Templeton ETF TrustCOMMON STOCKNov 6, 20269:45 AM ET13G/A2.20%50.8K shares−11.60 ppfrom 13.80%Below 5%Oct 30, 2026SEC
BRZEBraze, Inc.Nov 6, 20269:45 AM ET13G/A3.70%4.20M shares−9.90 ppfrom 13.60%Below 5%Oct 30, 2026SEC
MMEDMiniMed Group, Inc.Nov 6, 20269:45 AM ET13G13.50%37.9M sharesNewOct 30, 2026SEC
TRAXFirst Tracks Biotherapeutics, Inc.Nov 6, 20269:45 AM ET13G/A15.00%6.30M shares+9.10 ppfrom 5.90%Oct 30, 2026SEC